CLPTM1L Antikörper (C-Term)
Kurzübersicht für CLPTM1L Antikörper (C-Term) (ABIN951580)
Target
Alle CLPTM1L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 508-538, C-Term
-
Spezifität
- This antibody reacts to CLPTM1L.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide selected between amino acids 508-538 of human CLPTM1L
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CLPTM1L (CLPTM1-Like (CLPTM1L))
-
Andere Bezeichnung
- CLPTM1-Like Protein
-
Hintergrund
- CLPTM1L enhances cisplatin-mediated apoptosis, when overexpressedSynonyms: CLPTM1L, CRR9, CRR9p, Cisplatin resistance-related protein 9, Cleft lip and palate transmembrane protein 1-like protein
-
Molekulargewicht
- 62229 Da
-
Gen-ID
- 81037
-
NCBI Accession
- NP_110409
Target
-